Rising numbers of assisted reproductive
procedures such as in vitro fertilization (IVF) is Asia is the most
prominent factor driving the market for preimplantation genetic
diagnosis. This is, in essence, the result of factors such as the
delayed age of conception among Asian women, the rising rate of
infertility among the population, and the significantly expanding
medical tourism industry in the region. Rising disposable incomes and
increased awareness regarding the rising prevalence of a number of
genetic disorders are also encouraging the Asian population to undertake
costly diagnostic procedures such as PGD.
Report Overview @ https://www.transparencymarketresearch.com/asia-preimplantation-genetic-diagnosis-market.html
TMR analysts project that these factors
will enable the Asia preimplantation genetic diagnosis market expansion
at a healthy 6.8% CAGR from 2015 to 2023. The market is expected to rise
from a valuation of US$16.0 mn in 2014 to US$28.8 mn by 2023.
Rising Preference for Single Gene Disorder Screening over Prenatal Diagnostic Testing to Drive Market
Preimplantation genetic diagnosis for the
screening of aneuploidy held the largest share of 34.7% in the Asia PGD
market in 2014. Liberal regulations pertaining to this area of
diagnosis in most Asian countries is the major factor behind the high
numbers of aneuploidy screening tests undertaken every year in the
region. However, PGD for single gene disorder is projected to expand at
the faster CAGR of 8.4% from the period between 2015 and 2023.
Increased preference of this diagnostic
modality is encouraged by technological advancements and relatively high
accuracy of results. Moreover, single gene disorder screening is more
beneficial compared to conventional prenatal diagnostic testing in
embryo, driving the market for PGD for single gene disorder.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9989
Rising Numbers of Healthcare Facilities to Boost Asia PGD Market
Known to provide excellent medical
services at highly economical rates as compared to developed regions,
the healthcare industry in Asia has invited patients from world over.
With continuous advancements in healthcare infrastructure, rising
numbers of healthcare experts, and constantly improving diagnostic
facilities, Asia is expected to be a major hub for the PGD market in the
future. Many global vendors in the healthcare and diagnostics industry
are extending their businesses in the region and the number of fertility
clinics, hospitals, and diagnostic centers are constantly rising in the
region.
Fertility clinics held a major share in
the overall Asia PGD market in 2014, and are expected to exhibit a 5.9%
CAGR from the period between 2015 and 2023. However, the segment of
healthcare facilities is expected to expand at a much better 7.8% CAGR
over the same period. The flourishing tourism industry in the region is
leading to the establishment of an increasing number of IVF centers and
healthcare facilities such as hospitals and diagnostic centers in the
region.
Asia PGD Market to Witness Highest Traction in Southern Countries
In the next few years, the Asia PGD
market is expected to witness the highest growth in Southern countries
such as India and China. The high and rising rate of infertility in
South Asian countries, rising disposable incomes, high percentage of
women in the workforce, and availability of technologically advanced
healthcare infrastructure will enable the region in presenting the most
attractive growth opportunities for the Asia PGD market. Countries in
Southern Asia will also benefit from the flourishing medical tourism
industry during the period between 2015 and 2023.
No comments:
Post a Comment